Fluconazole Dosing for Vaginal Yeast Infection
For uncomplicated vaginal yeast infection (vulvovaginal candidiasis), give fluconazole 150 mg as a single oral dose 1, 2.
Recommended Regimen
The standard treatment is straightforward:
- Fluconazole 150 mg orally, single dose
- No food restrictions—can be taken with or without meals 2
- Peak plasma levels occur 1-2 hours after administration 2
- Therapeutic vaginal tissue concentrations achieved within 48 hours 2
This recommendation comes directly from the 2021 CDC STI Treatment Guidelines and is supported by FDA labeling 1, 2. The single-dose regimen has demonstrated clinical cure rates of 74-94% and mycological eradication rates of 76-86% in multiple studies 3, 4, 5.
Clinical Context: Uncomplicated vs. Complicated VVC
Use this single-dose regimen ONLY for uncomplicated VVC, which is defined as:
- Mild-to-moderate symptoms
- Infrequent episodes (not recurrent)
- Likely Candida albicans infection
- Non-immunocompromised host
- Non-pregnant patient 1
Do NOT use single-dose fluconazole for complicated VVC, which includes severe symptoms, recurrent infections (≥4 episodes/year), non-albicans species, diabetes, or immunosuppression—these require longer treatment courses 1.
Efficacy Evidence
The single 150 mg dose performs equivalently to 3-7 day topical azole regimens:
- Clinical cure rates at 7-14 days: 85-94% 3, 4, 5
- Mycological eradication: 73-86% 3, 4, 5
- Sustained cure at 30-35 days: 75% 5
Importantly, patients with recurrent vaginitis history have significantly lower response rates (p<0.001), so consider alternative or extended regimens for this population 5.
Safety Profile
Adverse events are mild and infrequent:
- Most common: headache (13%), nausea (7%), abdominal pain (6%) 2
- Treatment discontinuation rate: only 1.5% 2
- Serious hepatic reactions are rare but monitor in patients with underlying liver disease 2
Important Caveats
Resistance considerations: Fluconazole-resistant C. albicans occurs in approximately 7% of cases at referral centers 6. If symptoms persist after treatment:
- Obtain fungal culture with susceptibility testing
- Consider non-albicans species (especially C. glabrata)
- Alternative: boric acid 600 mg intravaginally daily for 14 days has 86% mycological cure for resistant cases 6
Pregnancy: Fluconazole is contraindicated in pregnancy—use topical azoles instead 1.
Recurrent VVC: Single-dose therapy is inadequate. These patients require induction therapy followed by maintenance suppression (typically fluconazole 150 mg weekly for 6 months) 1.
The single 150 mg dose offers superior compliance compared to multi-day topical regimens while maintaining equivalent efficacy, making it the preferred first-line treatment for uncomplicated vaginal yeast infections 7, 8.